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Abstract
Of late, fungal infections are increasingly being recognized in diabetic patients. Here we
present a case of polymicrobial fungal empyema due
to Trichosporon species and Fusarium species developed after community-acquired pneumonia
in a diabetic patient. Trichosporon species are basidiomycetous yeast and Fusarium species are
soil saprophytes with a worldwide distribution. Fungal empyema cases are rare and are mostly
caused by Aspergillus and Candida species. Polymicrobial fungal empyema
with Trichosporon species and Fusarium species has not been reported previously. Our patient
was successfully treated with antifungal therapy. This case highlights that fungal empyema
should be considered in diabetic patients especially if they are not responding to antibiotics.
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Introduction
Empyema is mainly caused by bacterial agents; Streptococcus milleri, S. viridans, and S.
pneumoniae being the most common agents in community-acquired empyema [1]. Empyema is
rarely caused by fungi and Aspergillus species and Candida species are frequently reported
agents [2]. Risk factors for fungal empyema include diabetes, immunosuppression, invasive
surgical procedures with nonsterile equipments, and esophago- or gastro-pleural fistula [3-6].
Fungal infections have been increasingly recognized in diabetic patients because of their
altered immune status [7].
Trichosporon species are basidiomycetous yeast-like anamorphic pathogens which are generally
distributed in nature and found mainly in tropical and temperate areas. These organisms can
be found in soil, decomposing wood, air, rivers, lakes, sea water, cheese, cattle, scarab beetles,
pigeons, and bird droppings [8-10]. It can cause invasive infections in immunocompromised
patients whereas in immunocompetent hosts it results in allergic pneumonia and superficial
infections [11].
Fusarium species are soil saprophytes with a worldwide distribution and result in a broad
spectrum of infections, ranging from superficial to locally invasive or disseminated infections.
Severely immunocompromised patients suffer from disseminated infection while
immunocompetent individuals have allergic diseases and other disease manifestations [12-13].
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Here we are reporting a case of a diabetic patient who developed empyema
with Trichosporon species and Fusarium species after community-acquired pneumonia. The
patient was treated successfully with antifungal agents. This case highlights the significance of
super-added fungal infection as a cause of empyema in a diabetic patient with community-
acquired pneumonia.
Case Presentation
A 63-year old female was referred to our hospital with progressively increasing shortness of
breath for 15 days. She was being treated as a community-acquired pneumonia patient at some
other hospital. Her course of illness at that hospital was complicated with the development of
right-sided hydropneumothorax, for which she had underwent right-sided tube thoracostomy.
Her condition did not improve, and she was referred to our hospital. On presentation her blood
pressure was 110/60 mmHg, pulse was 110/min, and oxygen saturation was 95% on 10 L of
oxygen. She had severe subcutaneous emphysema on face and chest. There was a chest tube
placed on the right side. On chest auscultation bilateral crackles were audible. Rest of the
examination was unremarkable. She was a known case of hypertension and poorly controlled
diabetes mellitus, her glycated hemoglobin (HbA1c) on admission was 8.7%. She was on
metformin and Humulin N. During hospitalization her blood sugar remained elevated for
which Insulin Glargin 24 units was added with increased dose of Humulin N. There was no prior
history of diabetic neuropathy, retinopathy, or nephropathy.
On presentation her complete blood count showed hemoglobin of 12.7 g/dL and white cell
count of 14.8 x 103/L with 84.4% neutrophils. Blood urea nitrogen was 15 mg/dL, creatinine
was 1.0 mg/dL, and random blood sugar was 294 mg/dL. Chest radiograph revealed significant
subcutaneous emphysema with right-sided pneumothorax, pneumomediastinum along with
pneumopericardium (Figure 1). High resolution computed tomography (HRCT) scan confirmed
pneumothorax with pneumomediastinum, pneumopericardium, right-sided necrotizing
consolidation, and mal-positioning of chest tube (Figure 2).
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FIGURE 1: Chest X-ray showing bilateral subcutaneous
emphysema (blue arrow), pneumomediastinum (orange arrow),
and right-sided pneumothorax (red arrow).
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FIGURE 2: High resolution CT chest showing right cavitation
(orange arrow) with pneumothorax (red arrow) and
subcutaneous emphysema (blue arrow).
The patient was started on piperacillin/tazobactam, vancomycin, and a new chest tube was
inserted on the right side. Due to no improvement in her condition, surgical intervention was
planned. The patient refused surgical intervention and was discharged home on IV antibiotics
with chest tube on suction. She again presented 10 days later with fever and purulent discharge
from the chest tube. Pus was sent to laboratory for Gram stain and culture. Antibiotics were
changed to colistin and meropenem. Pleural fluid analysis showed total leukocyte count of
99020/cu mm with 90% polymorphs and glucose of 7 mg/dL. Gram stain of pleural pus revealed
numerous pus cells and fungal hyphae on smear and culture grew Trichosporon spp.
and Fusarium spp. Fusarium spp. was identified based on phenotypic gross and microscopic
morphology, while Trichosporon spp. was identified to genus level based on colony morphology,
urease production, and microscopic morphology on corn meal agar. Susceptibility testing for
both organisms was not performed. No bacterial growth was obtained on sputum, blood, and
pleural culture. As tuberculosis is endemic in Pakistan, she was also evaluated for TB and
mycobacterial culture was negative.
Amphotericin B deoxycholate was started and antibiotics were stopped after the third day of
admission. Empyema was drained through chest tube and the chest tube was kept in place for
eight weeks. She became afebrile after initiation of antifungal but developed acute kidney
injury, electrolyte imbalance, and vomiting. Amphotericin B was replaced with voriconazole
200 mg twice daily which was continued for eight weeks. She tolerated the treatment very well
and her condition improved gradually, and the chest tube was successfully removed after eight
weeks. Follow up chest radiograph showed significant improvement (Figure 3).
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FIGURE 3: Chest X-ray after treatment showing fibrotic
changes (arrow) at right middle zone.
Discussion
Fungal empyema itself is a rare entity with Aspergillus spp. and Candida spp. as the most
commonly reported organisms [2-6]. Although isolated cases of empyema with Fusarium spp.
and Trichosporon spp. have been reported co-infection with both organisms has not been
reported previously [14]. Fungal empyema has been reported mainly in patients with
immunosuppression, brochopulmonary infection, and postabdominal or chest surgery.
Mortality in these cases remains high if not diagnosed and left untreated. Our patient was
treated successfully with antifungal without any surgical intervention.
Treatment of empyema could be surgical with video-assisted thoracoscopic surgery (VATS) or
open thoracotomy and nonsurgical such as thoracentesis and chest tube drainage with or
without fibrinolytic agents [15]. Despite receiving surgery and pleural irrigation with antifungal
agents the crude mortality rate has been reported to be as higher as 73% in fungal empyema [2].
Treatment of fungal empyema is not standardized and several drugs can be used [16]. Our
patient refused surgical intervention so she was managed with chest tube drainage and
systemic antifungal therapy.
Trichosporon can colonize different parts of human body. This pathogen is also able to cause
deep-seated, mucosa-associated, or superficial infections. Invasive trichosporonosis has been
observed commonly in immunosuppressed patients or with hematological malignancies and in
critically ill patients who have been exposed to multiple invasive medical procedures [8-10].
Similarly Fusarium can also be a colonizer but can cause invasive infection in
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immunocompromised host [12]. Treatment of both of these fungi is species specific with some
of the species having higher minimum inhibitory concentrations with amphotericin or azoles.
We identified these organisms up to genus level only and susceptibility testing was also not
performed.
Our patient had no other apparent risk factor of fungal infection except diabetes. However, the
patient had had ICU admission, underwent invasive procedure like chest tube insertion, and
received multiple broad spectrum antibiotics; all of which could increase the risk of invasive
fungal infection. The other possibility is colonization but our patient did not grow any bacteria
throughout her illness and did not show any improvement despite being on broad spectrum
antibiotics. The patient showed significant improvement after adding antifungal therapy.
This suggests that these organisms were pathogens and not a colonizer in our patient.
Conclusions
Our case highlights the importance of super-added fungal infection especially if patients do not
respond to the conventional antibiotic therapy. Failure of treatment should raise the suspicion
of other organisms as diabetic patients are at higher risk of not only bacterial but also of fungal
infections. Early diagnosis and management lead to good clinical outcome.
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